Pfenex, Agila take on biosimilars; Teva shrinking manufacturing; FDA looking for user fees IDs;

> U.S.-based Pfenex has create a joint venture with Agila Biotech, a subsidiary of India's Strides Arcolab, for the development and manufacture of 6 biosimilar products. Report

> The FDA faces challenges of providing oversight to manufacturing operations around the world. Presentation (PDF)

> Teva Pharmaceutical Industries ($TEVA) has started the process of cutting costs by improving procurement costs and reducing the footprint of its manufacturing network, CEO Jeremy Levin said. Story

> The FDA is asking API and generic drugmakers to self identify so the agency can collect user fees. Report

> CPhI Worldwide and its content partner Pharma Evolution will launch a series of trend next month on formulations and ingredients, the first in a monthly series of reports which will be combined and released in September. Release

And Finally... New manufacturing processes are expected to dramatically speed the time drugmakers will get a bird flu vaccine to market. Story